Versant Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-62
| Closed | -$545 | – | 1963 |
|
|
2023
Q4 | $545 | Buy |
+62
| New | +$545 | ﹤0.01% | 1656 |
|
|
2023
Q3 | – | Sell |
-14
| Closed | -$354 | – | 2083 |
|
|
2023
Q2 | $354 | Buy |
+14
| New | +$354 | ﹤0.01% | 1897 |
|
|
2021
Q4 | – | Sell |
-12
| Closed | – | – | 1622 |
|
|
2021
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1636 |
|
|
2021
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1627 |
|
|
2021
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 1627 |
|
|
2020
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 1571 |
|
|
2020
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1551 |
|
|
2020
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1611 |
|
|
2020
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1755 |
|